CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleLevered free cash flow is $72.02M, above the global median of $18.73M
- FinancialsAltman Z-Score 5.33: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.38%Below 5Y avg (1.51%)
Annual Rate
CNY 0.22Paid annual
Payout Ratio
72.7%Moderate
Payback Period
76.2 yr
Last Ex-Dividend
Jun 2, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.42BCNY1.11B · vs all stocks (USD)
Revenue (TTM)
1.88BCNY280.49M · vs all stocks (USD)
Profit Margin
-6.90%vs Medical Devices peers
Beta
0.8170xvs all stocks
52-Week Change
-25.68%vs all stocks
Market Capitalization
7.42BCNY1.11B · vs all stocks (USD)
Enterprise Value
5.57BCNY831.11M · vs all stocks (USD)
Forward P/E
13.79xvs Medical Devices peers
Price to Sales (TTM)
3.95xvs Medical Devices peers
Price to Book (MRQ)
1.38xvs Medical Devices peers
Enterprise to Revenue
2.96xvs Medical Devices peers
Gross Margin
63.89%vs Medical Devices peers
Profit Margin
-6.90%vs Medical Devices peers
Operating Margin
9.67%vs Medical Devices peers
Return on Assets (TTM)
-1.67%vs Medical Devices peers
Return on Equity (TTM)
-2.42%vs Medical Devices peers
Revenue (TTM)
1.88BCNY280.49M · vs all stocks (USD)
Revenue per Share (TTM)
3.93CNYUpdated Sep 20, 2026Quarterly Revenue Growth
2.60%vs Medical Devices peers
Gross Profit (TTM)
1.05BCNY156.68M · vs all stocks (USD)
EBITDA (TTM)
190.61MCNY28.44M · vs all stocks (USD)
Net Income (TTM)
-129.70MCNY-19.35M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
59909.20%vs Medical Devices peers
Operating Cash Flow (TTM)
943.35MCNY140.77M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
482.66MCNY72.02M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2200CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
1.38%vs all stocks
5-Year Average Dividend Yield
1.51%vs all stocks
Payout Ratio
72.73%vs Medical Devices peers
Minority Interest (Equity)
58.93MCNYFY2025 · Dec 31, 2025Revenue
2.09BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
897.85MCNYFY2025 · Dec 31, 2025Gross Profit
1.19BCNYFY2025 · Dec 31, 2025Operating Income
-97.80MCNY-14.59M · vs all stocks (USD)
Pre-tax Income
-114.69MCNYFY2025 · Dec 31, 2025Income Tax Expense
-45.03MCNYFY2025 · Dec 31, 2025Net Income
-69.66MCNYFY2025 · Dec 31, 2025EBIT
-83.55MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
190.61MCNYFY2025 · Dec 31, 2025Research & Development
336.70MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
425.97MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
7.67MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
31.14MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1300CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
484.81MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
484.81MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-69.66MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
6.63MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
252.18MCNYFY2025 · Dec 31, 2025Free Cash Flow
-51.92MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
462.00MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-69.66MCNYFY2025 · Dec 31, 2025Other Non-cash Items
30.67MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
271.58MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
19.58MCNYFY2025 · Dec 31, 2025Capital Expenditures
-304.10MCNYFY2025 · Dec 31, 2025Net Acquisitions
1.01MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.77BCNYFY2025 · Dec 31, 2025Sale of Investments
4.66BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-417.46MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-197.64MCNYFY2025 · Dec 31, 2025Other Financing Charges
-209.77MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-407.40MCNYFY2025 · Dec 31, 2025Shares Outstanding
468.09MSharesUpdated Sep 20, 2026Float Shares
261.23MSharesUpdated Sep 20, 2026% Held by Insiders
47.08%vs all stocks
% Held by Institutions
6.28%vs all stocks
Total Cash (MRQ)
2.62BCNY390.45M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.53CNYUpdated Sep 20, 2026Total Debt (MRQ)
613.50MCNY91.55M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1114xvs Medical Devices peers
Current Ratio (MRQ)
3.31xvs Medical Devices peers
Book Value per Share (MRQ)
11.50CNYUpdated Sep 20, 2026Total Assets
6.60BCNY985.10M · vs all stocks (USD)
Total Current Assets
3.30BCNYFY2025 · Dec 31, 2025Total Liabilities
1.13BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.30BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
89.24MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.04BCNYFY2025 · Dec 31, 2025Cash
460.33MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.19MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
462.53MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.26BCNYFY2025 · Dec 31, 2025Accounts Receivable
774.19MCNYFY2025 · Dec 31, 2025Inventory
280.58MCNYFY2025 · Dec 31, 2025Accounts Payable
210.81MCNYFY2025 · Dec 31, 2025Short-term Debt
592.39MCNYFY2025 · Dec 31, 2025Other Current Liabilities
29.75MCNYFY2025 · Dec 31, 2025Long-term Debt
9.26MCNYFY2025 · Dec 31, 2025Common Stock (Book)
468.08MCNYFY2025 · Dec 31, 2025Retained Earnings
3.30BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.47BCNY816.76M · vs all stocks (USD)
Treasury Stock
30.09MCNYFY2025 · Dec 31, 202552-Week Low
15.40CNYUpdated Sep 20, 202652-Week High
26.29CNYUpdated Sep 20, 202652-Week Change
-25.68%vs all stocks
Beta
0.8170xvs all stocks
50-Day MA
16.78CNYUpdated Sep 20, 2026200-Day MA
18.65CNYUpdated Sep 20, 2026Avg 10-Day Volume
3.42MSharesUpdated Sep 20, 2026Avg 30-Day Volume
5.88MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
-0.2600CNYUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.64Profit Margin: -0.07
Financial Health
Altman Z-Score 5.33: safe zoneNotable
Altman Z-Score: 5.33
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Levered free cash flow is $72.02M, above the global median of $18.73MNotable
Levered free cash flow (USD): 72,022,596.826Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiuzhitang Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Wandong Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Amphastar Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Seegene, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Artivion Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shinva Medical Instrument Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hob Biotech Group Suzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sequent Scientific Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tandem Diabetes Care Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
BioGaia AB
Tier 1ProductionApproval-Gated PipelineRuleFlow